Document is current
Any future updates will be listed below
-
Authors
Okai, Takatsugu
Chan, Chim W.
KC, Achyut
Omondi, Protus
Musyoka, Kelvin
Kongere, James
Kagaya, Wataru
Okomo, Gordon
Kanoi, Bernard N.
Kido, Yasutoshi
Gitaka, Jesse
Kaneko, Akira
-
Funding
Funding for this research was provided by:
JST SPRING (JPMJSP2139)
Japan International Cooperation Agency/Japan Agency for Medical Research and Development (JICA/AMED) Science and Technology Research Partnership for Sustainable Development (20JM0110020H0002, 20JM0110020H0002)
Hitachi Fund Support for Research Related to Infectious Diseases
Japan Society for Promotion of Science (JSPS) KAKENHI Grant (22K0129)
Karolinska Institute
- License Information
-
More Information
Article History
Received: 20 September 2024
Accepted: 25 November 2024
First Online: 18 December 2024
Declarations
:
: Ethical approval was provided by the Kenyatta National Hospital/University of Nairobi Ethical Research Committee in Kenya (No. P7/1/2012), the Mount Kenya University Independent Ethical Research Committee (MKU–IERC; approval No. 1574, 2848 and 2565.), and the Ethics Committee of Osaka Metropolitan University (approval No. 3206). Written informed consent was obtained from all study participants or their parents or legal guardians in the case of minors under 16 years of age. Participants who tested positive for <i>P. falciparum</i> by RDT were given antimalarial treatment (artemether–lumefantrine) for free. The data set was anonymized; no personally identifiable information is included in this work.
: Not applicable.
: The authors declare no competing interests.
